These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 35381590

  • 1. Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy.
    Zhao S, Sun Y, Mao Q, Zhou C, Chen Y, Xue D.
    Nephron; 2022; 146(6):539-552. PubMed ID: 35381590
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
    Min QH, Chen XM, Zou YQ, Zhang J, Li J, Wang Y, Li SQ, Gao QF, Sun F, Liu J, Xu YM, Lin J, Huang LF, Huang B, Wang XZ.
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
    [Abstract] [Full Text] [Related]

  • 3. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
    Feng Y, Lv LL, Wu WJ, Li ZL, Chen J, Ni HF, Zhou LT, Tang TT, Wang FM, Wang B, Chen PS, Crowley SD, Liu BC.
    Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333
    [Abstract] [Full Text] [Related]

  • 4. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 5. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
    Li S, Hao H, Li R, Guo S.
    Tohoku J Exp Med; 2022 Mar 15; 256(3):215-223. PubMed ID: 35314529
    [Abstract] [Full Text] [Related]

  • 6. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Zhang Q, Zhao Y, Luo Y, Guo S, Hou H, Han X, Zhou Y.
    Ren Fail; 2024 Dec 15; 46(1):2319326. PubMed ID: 38379319
    [Abstract] [Full Text] [Related]

  • 7. Urinary exosomal miRNA signature of IgA nephropathy: a case-control study.
    Shankar M, Shetty A, N S M, C G S, A K, Tennankore K.
    Sci Rep; 2023 Dec 04; 13(1):21400. PubMed ID: 38049447
    [Abstract] [Full Text] [Related]

  • 8. Clinical and pathological correlation between urinary exosome miR-223 and IgAN patients.
    Song J, Qin X, Li H, Huang G, Bi H.
    Clin Nephrol; 2023 Nov 04; 100(5):209-215. PubMed ID: 37622669
    [Abstract] [Full Text] [Related]

  • 9. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
    Zhang M, Duan ZY, Zhang QY, Xu XG, Zhang Y, Wang P, Duan SW, Wu J, Chen XM, Cai GY.
    Sci Rep; 2023 Apr 13; 13(1):6048. PubMed ID: 37055445
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
    Yoon SY, Kim JS, Jung SW, Kim YG, Hwang HS, Moon JY, Lee SH, Seo JW, Seok J, Tae D, Jeong K.
    Sci Rep; 2023 Oct 11; 13(1):17201. PubMed ID: 37821628
    [Abstract] [Full Text] [Related]

  • 11. Urinary exosomal circular RNAs of sex chromosome origin are associated with gender-related risk differences of clinicopathological features in patients with IgA nephropathy.
    Luan R, Tian G, Zhang H, Shi X, Li J, Zhang R, Lu X.
    J Nephrol; 2022 May 11; 35(4):1069-1078. PubMed ID: 34292531
    [Abstract] [Full Text] [Related]

  • 12. Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis.
    Yu Y, Bai F, Qin N, Liu W, Sun Q, Zhou Y, Yang J.
    Nephron; 2018 May 11; 139(3):269-282. PubMed ID: 29539618
    [Abstract] [Full Text] [Related]

  • 13. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J, Peng T, Gao J, Jia X, Yan G, Wang Y.
    BMC Immunol; 2018 Jun 20; 19(1):18. PubMed ID: 29925312
    [Abstract] [Full Text] [Related]

  • 14. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
    Hu H, Wan Q, Li T, Qi D, Dong X, Xu Y, Chen H, Liu H, Huang H, Wei C, Zhou W, Jiang S, Mo Z, Liao F, Xu Q, He Y.
    Iran J Kidney Dis; 2020 Mar 20; 14(2):107-118. PubMed ID: 32165595
    [Abstract] [Full Text] [Related]

  • 15. Urinary miRNA profile for the diagnosis of IgA nephropathy.
    Szeto CC, Wang G, Ng JK, Kwan BC, Mac-Moune Lai F, Chow KM, Luk CC, Lai KB, Li PK.
    BMC Nephrol; 2019 Mar 04; 20(1):77. PubMed ID: 30832601
    [Abstract] [Full Text] [Related]

  • 16. A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression.
    Pawluczyk I, Nicholson M, Barbour S, Er L, Selvaskandan H, Bhachu JS, Barratt J.
    Kidney Int Rep; 2021 Aug 04; 6(8):2179-2188. PubMed ID: 34386667
    [Abstract] [Full Text] [Related]

  • 17. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
    Han Q, Zhang Y, Jiao T, Li Q, Ding X, Zhang D, Cai G, Zhu H.
    Nutr Diabetes; 2021 Jun 30; 11(1):24. PubMed ID: 34193814
    [Abstract] [Full Text] [Related]

  • 18. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.
    Wang N, Bu R, Duan Z, Zhang X, Chen P, Li Z, Wu J, Cai G, Chen X.
    PeerJ; 2015 Jun 30; 3():e990. PubMed ID: 26056621
    [Abstract] [Full Text] [Related]

  • 19. Urinary exosomal mRNAs as biomarkers for predicting the therapeutic effect of renin-angiotensin system inhibitors in IgA nephropathy patients.
    Zhao B, Wang M, Cong Y, Song A, Lu J, Xie K, Dai H, Gu L.
    Clin Chim Acta; 2024 Jul 15; 561():119750. PubMed ID: 38885756
    [Abstract] [Full Text] [Related]

  • 20. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.